Different studies use different concentrations, delivery systems, endpoints, and model organisms
Procedure: Intramuscular (IM) Injection, self-administered in frontal thigh area
It was characterized as a selective, membrane-permeable small-molecule inhibitor of nicotinamide N-methyltransferase in biochemical, adipocyte, and mouse research
Possible side effects or risks may include: Injection site pain, redness, or irritation Headache Nausea Fatigue Dizziness Fluid retention Changes in appetite Immune or allergic reactions Unwanted tissue effects Infection risk from improper injection technique Unknown long-term risks Because the long-term safety data for many emerging peptides remains limited, patients should be cautious about anyone promising guaranteed results or claiming that peptide therapy is risk-free
Importantly, experimental observations consistently show that AOD 9604 does not activate the growth hormone receptor or alter IGF-1 signaling pathways [4]
Request your consultation today at Infinity Med-Spa of Georgia